Enento Group Oyj
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 1 MARCH 2021 AT 1.00 P.M. EET
New shares in Enento Group entered into the Trade Register
A total of 27,795 new shares were subscribed for in Enento Group Plc’s share issue directed to the company key employees without consideration.
The new shares have been entered into the Trade Register on 1 March 2021. After the registration, the total number of the shares in the Company is 24,034,856 shares.
The new shares produce the right to dividends and other distribution of assets as well as other shareholder rights as of the registration date 1 March 2021.
Trading of new shares alongside the existing shares will commence on 2 March 2021.
ENENTO GROUP PLC
For further information:
Jukka Ruuska
CEO
Tel. +358 10 270 7111
Distribution:
Nasdaq Helsinki
Major media
enento.com/investors
Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 425 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2020 was 151,3 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jyske Bank22.12.2025 07:12:39 CET | Press release
Share repurchase programme: Transactions of week 51 2025
Jyske Bank22.12.2025 07:12:39 CET | Pressemeddelelse
Aktietilbagekøb: Transaktioner i uge 51 2025
F. Hoffmann-La Roche Ltd22.12.2025 07:00:00 CET | Press release
FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma
AMG Critical Materials N.V.22.12.2025 07:00:00 CET | Press release
AMG Lithium Receives Funding from German Federal Ministry for Economic Affairs and Energy
Ipsen Pharma22.12.2025 07:00:00 CET | Press release
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
